3D bioprinting of glioblastoma models.

The most common and malignant primary brain tumor in adults is glioblastoma (GBM). In vitro 3D brain models are needed to better understand the pathological processes underlying GBM and ultimately develop more efficient antineoplastic agents. Here, we describe the bioprinting methods that have been used to fabricate volumetric GBM models. We explain several factors that should be considered for 3D bioprinting, including bioinks, cells and construct designs, in relation to GBM modeling. Although 3D-bioprinted brain models are still to be improved, they have the potential to become a powerful tool for drug screening.

[1]  I. Nakano,et al.  Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications. , 2020, Journal of neurosurgery.

[2]  Yu Shrike Zhang,et al.  Recent Advances in Formulating and Processing Biomaterial Inks for Vat Polymerization‐Based 3D Printing , 2020, Advanced healthcare materials.

[3]  Mehmet S. Ozturk,et al.  High-resolution tomographic analysis of in vitro 3D glioblastoma tumor model under long-term drug treatment , 2020, Science Advances.

[4]  Kayla J. Wolf,et al.  Dissecting and rebuilding the glioblastoma microenvironment with engineered materials , 2019, Nature Reviews Materials.

[5]  A. Quiñones‐Hinojosa,et al.  Survival benefit of maximal resection for glioblastoma reoperation in the temozolomide era: a meta-analysis. , 2019, World neurosurgery.

[6]  P. Brown,et al.  Progress Toward Long-Term Survivors of Glioblastoma. , 2019, Mayo Clinic proceedings.

[7]  S. Willerth,et al.  Bioprinting a novel glioblastoma tumor model using a fibrin-based bioink for drug screening , 2019, Materials Today Chemistry.

[8]  Y. S. Zhang,et al.  3D bioprinting for oncology applications. , 2019, Journal of 3D printing in medicine.

[9]  Ning Hu,et al.  3D Bioprinting: from Benches to Translational Applications. , 2019, Small.

[10]  S. Paek,et al.  A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy , 2019, Nature Biomedical Engineering.

[11]  Marcel A. Heinrich,et al.  3D‐Bioprinted Mini‐Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics , 2019, Advanced materials.

[12]  Hye-Young Heo,et al.  Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy , 2018, Clinical Cancer Research.

[13]  S. Willerth,et al.  Direct Reprogramming of Glioblastoma Cells into Neurons Using Small Molecules. , 2018, ACS chemical neuroscience.

[14]  A. Olivi,et al.  Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes , 2018, British journal of neurosurgery.

[15]  Lorenzo Moroni,et al.  Biofabrication strategies for 3D in vitro models and regenerative medicine , 2018, Nature Reviews Materials.

[16]  Matija Snuderl,et al.  Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. , 2018, Biomaterials.

[17]  Steffen Dettling,et al.  When Immune Cells Turn Bad—Tumor-Associated Microglia/Macrophages in Glioma , 2018, International journal of molecular sciences.

[18]  Savas Tasoglu,et al.  Bioprinting for Neural Tissue Engineering , 2018, Trends in Neurosciences.

[19]  Steven D Chang,et al.  Single-Cell RNAseq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma , 2017, bioRxiv.

[20]  Dong-Woo Cho,et al.  3D Cell Printed Tissue Analogues: A New Platform for Theranostics , 2017, Theranostics.

[21]  Ali Khademhosseini,et al.  Extrusion Bioprinting of Shear‐Thinning Gelatin Methacryloyl Bioinks , 2017, Advanced healthcare materials.

[22]  이명구,et al.  Robbins and Cotran Pathologic basis of disease , 2017 .

[23]  Alberto Mantovani,et al.  Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.

[24]  Tao Xu,et al.  3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility , 2016, Biofabrication.

[25]  Ibrahim T. Ozbolat,et al.  Application areas of 3D bioprinting. , 2016, Drug discovery today.

[26]  Savas Tasoglu,et al.  Utilizing stem cells for three-dimensional neural tissue engineering. , 2016, Biomaterials science.

[27]  Qiulian Wu,et al.  A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. , 2016, Cancer research.

[28]  Ö. Türeci,et al.  Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines , 2016, Clinical Cancer Research.

[29]  T. Scheibel,et al.  Strategies and Molecular Design Criteria for 3D Printable Hydrogels. , 2016, Chemical reviews.

[30]  G. Bergers,et al.  Glioblastoma: Defining Tumor Niches. , 2015, Trends in cancer.

[31]  Jean J. Zhao,et al.  Bioprinting for cancer research. , 2015, Trends in biotechnology.

[32]  Claudia Fischbach,et al.  3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways. , 2015, Biomaterials.

[33]  Kyu-Sung Choi,et al.  Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2 , 2015, Nature Communications.

[34]  Hsin-I. Ma,et al.  An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior. , 2015, Journal of biomedical materials research. Part B, Applied biomaterials.

[35]  D. Bergles,et al.  Human astrocytes develop physiological morphology and remain quiescent in a novel 3D matrix. , 2015, Biomaterials.

[36]  Fan Yang,et al.  Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels. , 2014, Molecular pharmaceutics.

[37]  P. Searson,et al.  Influence of Basement Membrane Proteins and Endothelial Cell-Derived Factors on the Morphology of Human Fetal-Derived Astrocytes in 2D , 2014, PloS one.

[38]  Wim E Hennink,et al.  25th Anniversary Article: Engineering Hydrogels for Biofabrication , 2013, Advanced materials.

[39]  B. Duan,et al.  3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. , 2013, Journal of biomedical materials research. Part A.

[40]  G. Basso,et al.  Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting. , 2013, Biochemical pharmacology.

[41]  D. Zagzag,et al.  Mechanisms of glioma-associated neovascularization. , 2012, The American journal of pathology.

[42]  T. Batchelor,et al.  Antiangiogenic Therapy for Glioblastoma , 2012, Cancer journal.

[43]  Mauro Biffoni,et al.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.

[44]  A Ranella,et al.  Direct laser writing of 3D scaffolds for neural tissue engineering applications , 2011, Biofabrication.

[45]  T. Hasan,et al.  A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform. , 2011, Biotechnology journal.

[46]  Benito Munoz,et al.  Towards patient-based cancer therapeutics , 2010, Nature Biotechnology.

[47]  L. Kunz-Schughart,et al.  Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.

[48]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[49]  Tzvi Dwolatzky,et al.  Hazzard’s Geriatric Medicine and Gerontology , 2009 .

[50]  Michele Marcolongo,et al.  Characterization of cell viability during bioprinting processes. , 2009, Biotechnology journal.

[51]  Sanjay Kumar,et al.  The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. , 2009, Cancer research.

[52]  M. Dours-Zimmermann,et al.  Extracellular matrix of the central nervous system: from neglect to challenge , 2008, Histochemistry and Cell Biology.

[53]  Sunit Das,et al.  Cancer stem cells and glioma , 2008, Nature Clinical Practice Neurology.

[54]  R. Wells The role of matrix stiffness in regulating cell behavior , 2008, Hepatology.

[55]  Wenjun Guo,et al.  Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.

[56]  G. Reifenberger,et al.  The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[57]  K. Leong,et al.  The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. , 2002, Tissue engineering.

[58]  R. A. Davidoff From Neuron to Brain , 1977, Neurology.

[59]  A. Quiñones‐Hinojosa,et al.  Hypofractionated versus standard radiation therapy in combination with temozolomide for glioblastoma in the elderly: a meta-analysis , 2019, Journal of Neuro-Oncology.

[60]  Ji-hua Chen,et al.  Intrafibrillar silicified collagen scaffold modulates monocyte to promote cell homing, angiogenesis and bone regeneration. , 2017, Biomaterials.

[61]  Ibrahim T. Ozbolat,et al.  Current advances and future perspectives in extrusion-based bioprinting. , 2016, Biomaterials.

[62]  B. Kristensen,et al.  Chemoresistance and chemotherapy targeting stem-like cells in malignant glioma. , 2015, Advances in experimental medicine and biology.

[63]  Tabatabaei Qomi,et al.  The Design of Scaffolds for Use in Tissue Engineering , 2014 .

[64]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[65]  R V Bellamkonda,et al.  Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering. , 2007, Biomaterials.